The trial was tiny, just 16 patients, but it’s eliciting a sentiment not normally associated with this brutal disease of ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

These vaccines work by stimulating the body's immune response against cancer cells, often by training immune cells (like T ...

Pancreatic cancer is one of the deadliest and most difficult-to-detect forms of cancer. It kills nearly half a million people ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

A new study published in the journal Nature emphasizes the promise of a personalized vaccine, autogene cevumeran, in treating ...

Paired with an existing test, this could become a life-saving diagnostic tool for people with a notoriously deadly form of ...

Pancreatic cancer reprograms nerve cells to fuel its growth, but blocking these connections can shrink tumors and boost ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...

Pancreatic cancer is the third leading cause of cancer-related deaths in the country. The Ramone Foundation is hosting a ...

A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the disease from coming back. The trial was tiny, just 16 patients ...